Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07752186Completed
Randomised trial in atrophic acne scar (2 arms), sponsored by Lahore General Hospital. Primary endpoints: Patient and Observer Scar Assessment Scale Score at 12 weeks and Proportion of Participants Achieving Treatment Efficacy at 12 weeks. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07752186.